Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports

Our Views
Politics States Economy Society Business Culture Infra Defence World Books Ideas Science Technology Heritage Archives Legal Movies Sports
Magazine
Store

About Swarajya

Swarajya is a publication by Kovai Media Private Limited.

Swarajya - a big tent for liberal right of centre discourse that reaches out, engages and caters to the new India.

editor@swarajyamag.com

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Useful Links

About Us
Subscriptions Support
Editorial Philosophy
Press Kit

Privacy Policy
Terms of Use
Code of Conduct
Plagiarism Policy
Refund & Cancellation Policy

Participate

Contact Us
Write for us
Style Guide
Jobs

Stay Connected

SEC

‘If It Is Difficult For The Election Commissioner To Take Orders, He May Step Down’: Calcutta High Court Warns State Election Commission

The Calcutta High Court

'Misleading, Fallacious': Government On Media Reports Claiming Covaxin Approval Was Rushed Due To Political Pressure

Bharat Biotech's Covaxin

Explained: Why Chinese Companies Are Delisting From US Stock Exchanges

Joe Biden (left) and Xi Jinping.

Full Market Approval For Covishield, Covaxin: DCGI Panel To Meet Again Soon To Review Proposals

Covaxin and Covishield.

Govt's Expert Panel Recommends Emergency Use Approval For Zydus' ZyCoV-D, Second Indigenous COVID Vaccine: Report

ZyCoV-D (Pic Via Zydus Website)

U.S Crackdowns On Chinese IPOs Over Use Of 'Shell Companies', Stops Processing Registration Of IPOs Till New Regulatory Framework Is Set Up

Didi, China's ride hailing app.

DCGI's Expert Panel Says No To Covovax Trials On Children, Asks Serum Institute To Submit Safety Data First

Serum Institute of India (Pic Via Twitter)

Hetero Gets DCGI's Expert Panel Nod To Conduct Phase 3 Trials Of Russian Sputnik V Covid Vaccine In India

Russian Sputnik V Covid-19 vaccine (Pic Via Sputnik V website)

India Gets Third Covid-19 Vaccine As DCGI Approves Use Of Russian Sputnik V After Expert Panel's Recommendation

Russian Sputnik V Covid-19 vaccine (Pic Via Sputnik V website)

Indian Drug Regulator's Expert Panel Asks For More Data To Recommend Emergency Use Of Russian Sputnik V COVID-19 Vaccine

Russian Sputnik V Covid-19 vaccine (Pic Via Sputnik V website)

Bharat Biotech Plans Covaxin Testing On Children As Young As Two Years; To Submit A Proposal To DCGI's Expert Panel Soon

Bharat Biotech's COVAXIN, India’s first indigenous vaccine against Coronavirus. (Swarajya Magazine)

Boost To India's Fight Against Covid-19: Emergency Use Approval Recommended For SII's Covishield, Bharat Biotech's Covaxin

Bharat Biotech's COVAXIN, India’s first indigenous vaccine against Coronavirus. (Swarajya Magazine)

Bharat Biotech Set To Begin Phase 3 Clinical Trials Of Its Indigenous Covid-19 Vaccine 'Covaxin', Seeks DCGI Nod

Bharat Biotech's COVAXIN (Representative Image) (Pic Via BBIL Website)

Goa Government To Make Wearing Of Masks Mandatory For Purchase Of Petrol, Rations

A Mask

The Musk Is Off, It Seems: As US Stock Regulator Sues Tesla CEO For ‘Fraud’, Company Shares Plunge 13 Per Cent

Tesla Motors CEO Elon Musk (HECTOR GUERRERO/AFP/Getty Images)

Panchayat Polls: Bid To Browbeat Opposition Is Blowing Up In Trinamool’s Face

Jaideep Mazumdar

Bengal Chief Minister Mamata Banerjee during an event in New Delhi.  (Sonu Mehta/Hindustan Times via Getty Images)

With A Value Mark-Down To $5.5 Billion, Flipkart Is Now Ripe For Takeover

Flipkart headquarters in Bengaluru. Photo credit: GettyImages

Get Swarajya in your inbox.